Download high resolution picture

President & CEO

Born: 1970

Nationality: Danish

No. of shares in Coloplast: 90,691 B shares
(no change since 2020/21 Full-Year Financial Results)

With Coloplast since: 2008

Previous responsibilities in Coloplast:
- Senior Vice President, Global Marketing and Commercial Excellence
- Senior Vice President, Region Europe
- Senior Vice President, Emerging Markets
- Executive Vice President, Chronic Care

Other board and management positions:
- Demant A/S: Board member and member of the audit committee

Kristian Villumsen holds a MA in Political Science from Aarhus University and a MA in Public Policy from Harvard University

Download high resolution picture

Executive Vice President, CFO

Born: 1972

Nationality: Danish

No. of  shares in Coloplast: 0
(no change since 2020/21 Full-Year Financial Results)

With Coloplast since: 2006

Previous responsibilities in Coloplast:
- Chief Business Controller, Ostomy Care
- Director Performance Management
- Chief Information Officer

Anders Lonning-Skovgaard is responsible for IT, Finance, Legal, Business Ethics, Intellectual property, Coloplast Business Centre in Poland and Investor Relations

Anders Lonning-Skovgaard holds a MSc in Finance and Accounting from Aarhus University

Download high resolution picture

Executive Vice President, Innovation

Born: 1969 

Nationality: Danish

No. of shares in Coloplast: 0
(no change since 2020/21 Full-Year Financial Results)

With Coloplast since: 2005

Previous responsibilities in Coloplast:
- Senior Vice President, Commercial Development & Ostomy Care
- Vice President & General Manager, Sales Nordic Region
- Senior Vice President, Global Wound Care

Nicolai Buhl Andersen holds a MA in Economics & Business from Copenhagen Business School and Sophia University in Japan

Download high resolution picture

Executive Vice President, Growth

Born: 1966

Nationality: Australian

No. of shares in Coloplast: 0
(no change since 2020/21 Full-Year Financial Results)

With Coloplast since: 2015

Previous responsibilities in Coloplast:
- Senior Vice President, Emerging Markets
- Executive Vice President, Chronic Care

Paul Marcun holds a MBA in Corporate Finance & Marketing from Sydney University of Technology

Download high resolution picture

Executive Vice President, Global Operations

Born: 1967

Nationality: Danish

No. of shares in Coloplast: 310 B shares
(no change since 2020/21 Full-Year Financial Results)

With Coloplast since: 1992

Previous responsibilities in Coloplast:
- Mechanical engineer
- Production Centre Manager
- Plant Manager
- Site Director
- General Manager
- Director, Volume Production
- Vice President, Corporate Procurement
- Senior Vice President, Global Operations

Allan Rasmussen holds a BPSE, IMD, E*MBA from Scandinavian International Management Institute, and a BSc (Mech. Eng.), from Technical University of Denmark

Download high resolution picture

Chairman

Born: 1959

Nationality: Danish

No. of shares in Coloplast: 207,392 B shares
(no change since 2020/21 Full-Year Financial Results)

Joined the board in 2018

Chairman of the Remuneration and Nomination Committee
Member of the Audit Committee

Other board and management positions:

- H. Lundbeck A/S: Chairman of the Board, chairman of the remuneration and nomination committee and member of the audit committee
- Chairman of the Danish Committee on Corporate Governance
- Chairman of the Life Science Council established by the Danish Government
- Limacorporte SpA: Chairman of the Board
- Gyldendal A/S: Member of the board

Lars Rasmussen acted as Coloplast’s President & CEO from 2008 – 2018 and was a member of Coloplast’s executive management from 2001 - 2018. Lars Rasmussen has extensive executive management and board experience from international listed companies in the med-tech and pharma industry. Lars Rasmussen possesses in-dept knowledge within commercialisation of innovation, B2B and B2C sales models and efficiency improvements.

Lars Rasmussen holds a Bachelor of Science degree in Engineering from Aalborg University and an Executive MBA from SIMI.

Lars Rasmussen is not considered independent.

Download high resolution picture

Deputy Chairman

Born: 1947

Nationality: Danish

No. of shares in Coloplast: 12,245,000 A shares & 32,517,865 B shares
In addition to the personally held shares, Niels Peter Louis-Hansen's wholly-owned company N.P. Louis-Hansen ApS owns 1,134,850 B shares
(no change since 2020/21 Full-Year Financial Results)

Joined the board in 1968

Member of the Remuneration and Nomination Committee

Other board and management positions:
- Aage og Johanne Louis-Hansens Fond: Chairman of the Board
- Aage og Johanne Louis-Hansen A/S: Chairman of the Board
- N.P. Louis-Hansen ApS: CEO
- NPLH Anpartsinvest ApS: CEO
- NPLH Property Investments ApS: CEO

Through decades of board work, Niels Peter Louis-Hansen has gained in-dept knowledge of the industries in which Coloplast operates, its dynamics and key players as well as deep insight into strategy development. Furthermore, Niels Peter Louis-Hansen is a key contributor to preserving the Coloplast-culture.

Niels Peter Louis-Hansen holds a degree as Civiløkonom.

Niels Peter Louis-Hansen is not considered independent.

Download high resolution picture

Board Member

Born: 1964

Nationality: Danish

No. of shares in Coloplast: 6,000 B shares
(no change since 2020/21 Full-Year Financial Results)

Joined the board in 2017

Member of the Audit Committee

Other board and management positions:
- ALK-Abelló A/S: President & CEO
- The Danish Chamber of Commerce: Board member

Carsten Hellmann has considerable executive management experience. Since 2016 Carsten Hellmann has been the President & CEO in ALK-Abelló A/S, a listed pharmaceutical company. Prior to that, Carsten Hellmann held several top management and CEO positions in the Health Care industry, latest as CEO of Merial in France and member of the Executive Committee of the French pharmaceutical company Sanofi. Carsten Hellmann has extensive experience in product development and international commercialization within highly regulated industries as well as M&A activities, including post integration.

Carsten Hellmann holds a BSc in Business Administration from Copenhagen Business School and a MSc in Information Management from Lancaster University.

Carsten Hellmann is considered independent.

Download high resolution picture

Board Member

Born: 1971

Nationality: Belgian

No. of shares in Coloplast: 0
(no change since 2020/21 Full-Year Financial Results)

Joined the board in 2021

Member of the Remuneration and Nomination Committee

Other board and management positions:
- Medela AG: CEO

Annette Brüls has considerable executive management experience within global medical device businesses. She has since 2018 been CEO of Medela AG, one of the world’s leading providers of breastfeeding products and medical vacuum technology. Prior to that, Annette Brüls spent 11 years with Medtronic holding several senior leadership positions in both Europe and the US. Annette Brüls has in-depth knowledge and understanding of product development and commercialization within the med-tech industry and in particular in chronic disease management, including digital services and value-based healthcare models.

Annette Brüls has an engineering degree in medical and electronic engineering from the University of Liège in Belgium.

Annette Brüls is considered independent.

Download high resolution picture

Board Member

Born: 1968

Nationality: Danish

No. of shares in Coloplast: 0
(no change since 2020/21 Full-Year Financial Results)

Joined the board in 2015

Member of the Remuneration and Nomination Committee

Other board and management positions:
- BetMGM, LLC: Board member
- Entain plc: CEO and Executive Director

Jette Nygaard-Andersen has held numerous international management positions. Currently, Jette Nygaard-Andersen is acting as CEO and Executive Director in Entain plc. Jette Nygaard-Andersen has considerable executive management and board experience within global med-tech, media & entertainment, and digital growth businesses. Jette Nygaard-Andersen has extensive experience within business and marketing strategies, digital transformation, optimization of customer experience and customer engagement, working with digital growth start-ups globally and M&A activities, including post integration.

Jette Nygaard-Andersen holds a MSc in Business, Finance & Economics from the University of Copenhagen and Executive Development Programs from INSEAD and Executive Leadership Programmes from Columbia University.

Jette Nygaard-Andersen is considered independent.

Download high resolution picture

Board Member

Born: 1965

Nationality: Norwegian

No. of shares in Coloplast: 500 B shares
(bought on 26 January 2022)

Joined the board in 2020

Chairman of the Audit Committee

Other board and management positions:
- Norsk Hydro ASA (BM) and chairman of the audit committee
- WS Audiology A/S, CFO

Marianne Wiinholt has considerable executive management experience. From April 2022, Marianne Wiinholt has acted as CFO in WS Audiology A/S which was formed in 2019 through the merger of Sivontos and Widex. Previously, Marianne Wiinholt acted as CFO in Ørsted A/S, a listed company in the energy sector. Prior to becoming CFO in Ørsted A/S, Marianne Wiinholt held several management positions in Ørsted A/S. Marianne Wiinholt has extensive experience within finance and accounting and considerable knowledge and experience in leading, driving and delivering a sustainability agenda on a global scale.

Marianne Wiinholt holds a MSc in Business Administration and Auditing and is qualified State Authorised Public Accountant.

Marianne Wiinholt is considered independent.